CBR International Corp.® is an integrated development company supporting all aspects of the product development life cycle including clinical, scientific, quality and regulatory. With clients around the globe, CBR provides services to support filings and approvals in the United States, Europe, Canada, South America, Asia and Australia. CBR has expertise across a wide range of indications for drugs, novel antibodies, recombinant protein therapeutics, small molecules, vaccines, cell therapy, device and combination products throughout all phases of program development (Phase I – IV) and commercialization.
CBR Biotech Strategies GmbH, in partnership with CBR International Corp® and TruSubmit LLC, is a European-based company that specializes in providing corporate strategy for overall product development. We have formed strategic alliances to provide integrative program and strategic development for the biotech, pharmaceutical and medical device industries. Our expertise and international network of experienced professionals is a valuable resource in helping you develop your product and bring it to market. As global regulatory consultants, we work heavily with U.S. and international clients. Consequently, we excel in European Medicines Agency (EMA) and US Food and Drug Administration (FDA) pharmaceutical regulatory representation.